2011
DOI: 10.1371/journal.pone.0018297
|View full text |Cite
|
Sign up to set email alerts
|

Factors Associated with Colposcopy-Histopathology Confirmed Cervical Intraepithelial Neoplasia among HIV-Infected Women from Rio De Janeiro, Brazil

Abstract: IntroductionDespite the availability of preventive strategies (screening tests and vaccines), cervical cancer continues to impose a significant health burden in low- and medium-resourced countries. HIV-infected women are at increased risk for infection with human papillomavirus (HPV) and thus development of cervical squamous intraepithelial neoplasia (CIN).MethodsStudy participants included HIV-infected women enrolling the prospective open cohort of Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
23
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 26 publications
1
23
1
Order By: Relevance
“…A recent review of cervical cancer and HPV burden in China estimated the prevalence of high-risk HPV DNA to be 17.2% (Shi et al, 2011), a figure much lower than the 43.1% found in our population of HIV-infected women. While not as high as the 70 to 80% or higher prevalence estimates from HIV-infected women in sub-Saharan African countries with generalized HIV epidemics (e.g., Zambia (Sahasrabuddhe et al, 2007), South Africa (Denny et al, 2008) and Kenya (Luchters et al, 2010)), these rates are similar to those reported from studies reporting HPV DNA prevalence among HIV-infected women from countries with low-level or concentrated HIV epidemics like India (Sahasrabuddhe et al, 2010), Brazil (de Andrade et al, 2011), and elsewhere (Tornesello et al, 2008; Videla et al, 2009). …”
Section: Discussionsupporting
confidence: 67%
“…A recent review of cervical cancer and HPV burden in China estimated the prevalence of high-risk HPV DNA to be 17.2% (Shi et al, 2011), a figure much lower than the 43.1% found in our population of HIV-infected women. While not as high as the 70 to 80% or higher prevalence estimates from HIV-infected women in sub-Saharan African countries with generalized HIV epidemics (e.g., Zambia (Sahasrabuddhe et al, 2007), South Africa (Denny et al, 2008) and Kenya (Luchters et al, 2010)), these rates are similar to those reported from studies reporting HPV DNA prevalence among HIV-infected women from countries with low-level or concentrated HIV epidemics like India (Sahasrabuddhe et al, 2010), Brazil (de Andrade et al, 2011), and elsewhere (Tornesello et al, 2008; Videla et al, 2009). …”
Section: Discussionsupporting
confidence: 67%
“…Patients with histologically confirmed squamous intraepithelial lesion (SIL, n = 231) were enrolled consecutively from two cohorts followed at Fiocruz Clinical Care Units in Rio de Janeiro, RJ, Brazil: Fernandes Figueira Woman, Child and Adolescent National Institute (IFF, n = 182), and Evandro Chagas National Institute of Infectious Diseases (INI, n = 49). All patients received free appropriate clinical treatment [19] and provided written consent approved by the Institutional Review Board from INI and IFF/Fiocruz. HIV status was identified in all volunteers.…”
Section: Study Populationmentioning
confidence: 99%
“…5 In addition, HIV-infected women also, are frequently infected with multiple HPV types, and have a higher chance of presenting with a persistent infection or progression of these lesions to invasive cancer. 6 The conventional Pap smear is the standard screening test for cervical neoplasia in Kenya. Despite its success, the Pap smear has high false-negative rates due to poor sensitivity (51%; 95% confidence interval [CI], 0.37-0.66).…”
Section: Introductionmentioning
confidence: 99%